C08F120/36

POLYMER COMPOUND, SURFACE TREATMENT AGENT, LAMINATED BODY USING SURFACE TREATMENT AGENT, TRANSISTOR, METHOD FOR MANUFACTURING LAMINATED BODY

Provided is a compound which is excellent terms of stability and tight adhesion to substrates and on which wiring can be formed by electroless plating. The compound is a high-molecular-weight compound having a constituent unit represented by the following formula (1). [In formula (1), R1 represents a hydrogen atom or a methyl group, m is an integer of 2-20, and Q represents a photosensitive leaving group.]

CARBOHYDRATE LIGANDS THAT BIND TO IGM ANTIBODIES AGAINST MYELIN-ASSOCIATED GLYCOPROTEIN
20220185838 · 2022-06-16 ·

The invention relates to carbohydrate ligands presenting the minimal Human Natural Killer-1 (HNK-1) epitope that bind to anti-MAG (myelin-associated glycoprotein) IgM antibodies, and their use in diagnosis as well as for the treatment of anti-MAG neuropathy. In particular, the invention relates to disaccharides of formula (I) and (II) wherein Z is optionally substituted phenyl, heteroaryl, arylcarbonyl, or heteroarylmethyl, and to therapeutically acceptable polymers comprising a multitude of substituents of formula (I) and/or formula (II), wherein Z is a bifunctional linker connecting the disaccharides to the polymer backbone.

CARBOHYDRATE LIGANDS THAT BIND TO IGM ANTIBODIES AGAINST MYELIN-ASSOCIATED GLYCOPROTEIN
20220185838 · 2022-06-16 ·

The invention relates to carbohydrate ligands presenting the minimal Human Natural Killer-1 (HNK-1) epitope that bind to anti-MAG (myelin-associated glycoprotein) IgM antibodies, and their use in diagnosis as well as for the treatment of anti-MAG neuropathy. In particular, the invention relates to disaccharides of formula (I) and (II) wherein Z is optionally substituted phenyl, heteroaryl, arylcarbonyl, or heteroarylmethyl, and to therapeutically acceptable polymers comprising a multitude of substituents of formula (I) and/or formula (II), wherein Z is a bifunctional linker connecting the disaccharides to the polymer backbone.

CURED PRODUCT OF CURABLE MATERIAL, METHOD FOR PRODUCING CURED PRODUCT, AND POLYMER COMPOSITION
20220144980 · 2022-05-12 · ·

A cured product of a curable material is a cured product of a curable material containing a benzoxazine compound and a polymerization initiator. The benzoxazine compound has a polymerizable functional group on a nitrogen atom constituting an oxazine ring. The cured product has a curing rate of 60% or more. The present invention also encompasses a polymer composition including a polymer including repeating units of a polymerizable monomer having a benzoxazine ring.

ADHESIVE COMPOSITION THAT EASILY DISINTEGRATES IN WATER
20210363393 · 2021-11-25 ·

An easily water-disintegrable adhesive composition contains a 2-cyanoacrylate compound and a water-soluble compound, and wherein a cured product of the adhesive composition has a water absorption rate of 5% or higher when immersed in 40° C. water for 24 hours. The cured product of the adhesive composition preferably has a water absorption rate of 5% or higher when immersed in 23° C. water for 24 hours.

ADHESIVE COMPOSITION THAT EASILY DISINTEGRATES IN WATER
20210363393 · 2021-11-25 ·

An easily water-disintegrable adhesive composition contains a 2-cyanoacrylate compound and a water-soluble compound, and wherein a cured product of the adhesive composition has a water absorption rate of 5% or higher when immersed in 40° C. water for 24 hours. The cured product of the adhesive composition preferably has a water absorption rate of 5% or higher when immersed in 23° C. water for 24 hours.

Carbohydrate ligands that bind to IgM antibodies against myelin-associated glycoprotein

The invention relates to carbohydrate ligands presenting the minimal Human Natural Killer-1 (HNK-1) epitope that bind to anti-MAG (myelin-associated glycoprotein) IgM antibodies, and their use in diagnosis as well as for the treatment of anti-MAG neuropathy. In particular, the invention relates to disaccharides of formula (I) and (II) wherein Z is optionally substituted phenyl, heteroaryl, arylcarbonyl, or heteroarylmethyl, and to therapeutically acceptable polymers comprising a multitude of substituents of formula (I) and/or formula (II), wherein Z is a bifunctional linker connecting the disaccharides to the polymer backbone. ##STR00001##

Carbohydrate ligands that bind to IgM antibodies against myelin-associated glycoprotein

The invention relates to carbohydrate ligands presenting the minimal Human Natural Killer-1 (HNK-1) epitope that bind to anti-MAG (myelin-associated glycoprotein) IgM antibodies, and their use in diagnosis as well as for the treatment of anti-MAG neuropathy. In particular, the invention relates to disaccharides of formula (I) and (II) wherein Z is optionally substituted phenyl, heteroaryl, arylcarbonyl, or heteroarylmethyl, and to therapeutically acceptable polymers comprising a multitude of substituents of formula (I) and/or formula (II), wherein Z is a bifunctional linker connecting the disaccharides to the polymer backbone. ##STR00001##

Photopolymerization initiator

The present application provides a photopolymerization initiator having one or more ethylenic unsaturated bonds and one or more photopolymerization initiating functional groups in the molecule has been found. One or more kinds selected from an acrylamide group, an acrylate group, a vinyl group, an allyl group, a maleimide group, and the like can be suitably used as the ethylenic unsaturated bond, and a benzophenone compound having a specific structure can be suitably used as the photopolymerization initiating functional group.

Photopolymerization initiator

The present application provides a photopolymerization initiator having one or more ethylenic unsaturated bonds and one or more photopolymerization initiating functional groups in the molecule has been found. One or more kinds selected from an acrylamide group, an acrylate group, a vinyl group, an allyl group, a maleimide group, and the like can be suitably used as the ethylenic unsaturated bond, and a benzophenone compound having a specific structure can be suitably used as the photopolymerization initiating functional group.